{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:18:07Z","timestamp":1780960687396,"version":"3.54.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31872732"],"award-info":[{"award-number":["31872732"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91542113"],"award-info":[{"award-number":["91542113"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["021414380342"],"award-info":[{"award-number":["021414380342"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.bbadis.2018.10.007","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T02:21:58Z","timestamp":1538619718000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["mTOR inhibitor INK128 attenuates systemic lupus erythematosus by regulating inflammation-induced CD11b+Gr1+ cells"],"prefix":"10.1016","volume":"1865","author":[{"given":"Guoping","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayi","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2018.10.007_bb0005","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrd4227","article-title":"Systemic lupus erythematosus and lupus nephritis","volume":"13","author":"Koutsokeras","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0010","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0015","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.coi.2012.10.004","article-title":"The pathogenesis of systemic lupus erythematosus-an update","volume":"24","author":"Choi","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0020","series-title":"Myeloid Populations in Systemic Autoimmune Diseases","first-page":"198","volume":"vol. 53","author":"Morell","year":"2017"},{"key":"10.1016\/j.bbadis.2018.10.007_bb0025","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nrc3581","article-title":"History of myeloid-derived suppressor cells","volume":"13","author":"Talmadge","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2018.10.007_bb0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0035","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/art.38259","article-title":"Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cells","volume":"66","author":"Lourenco","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0040","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/art.39767","article-title":"Myeloid-derived suppressor cells induce the expansion of regulatory B cells and ameliorate autoimmunity in the sanroque mouse model of systemic lupus erythematosus","volume":"68","author":"Park","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0045","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/art.38048","article-title":"Gr-1(high) CD11b+ cells suppress B cell differentiation and lupus-like disease in lupus-prone male mice","volume":"65","author":"Trigunaite","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0050","doi-asserted-by":"crossref","first-page":"331ra340","DOI":"10.1126\/scitranslmed.aae0482","article-title":"Arginase-1-dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus","volume":"8","author":"Wu","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0055","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/art.39441","article-title":"Elimination of granulocytic myeloid-derived suppressor cells in lupus-prone mice linked to reactive oxygen species-dependent extracellular trap formation","volume":"68","author":"Vlachou","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0060","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/abbs\/gmv053","article-title":"17beta-estradiol contributes to the accumulation of myeloid-derived suppressor cells in blood by promoting TNF-alpha secretion","volume":"47","author":"Dong","year":"2015","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0065","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1042\/CS20160311","article-title":"Myeloid-derived suppressor cells contribute to systemic lupus erythaematosus by regulating differentiation of Th17 cells and Tregs","volume":"130","author":"Ji","year":"2016","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0070","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3389\/fimmu.2018.01443","article-title":"Myeloid-derived suppressor cells induce podocyte injury through increasing reactive oxygen species in lupus nephritis","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0075","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/imr.12383","article-title":"Endosomal Toll-like receptors in clinically overt and silent autoimmunity","volume":"269","author":"Clancy","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0080","doi-asserted-by":"crossref","first-page":"F59","DOI":"10.1084\/jem.194.12.f59","article-title":"A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus","volume":"194","author":"Ronnblom","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0085","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/BOR.0b013e32835c7e32","article-title":"The interferon signature in autoimmune diseases","volume":"25","author":"Ronnblom","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0090","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1586\/eci.12.106","article-title":"Fueling autoimmunity: type I interferon in autoimmune diseases","volume":"9","author":"Di Domizio","year":"2013","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0095","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/BOR.0b013e3283562c3e","article-title":"Type I IFN system in the development and manifestations of SLE","volume":"24","author":"Elkon","year":"2012","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0100","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.coi.2013.10.006","article-title":"TLRs and interferons: a central paradigm in autoimmunity","volume":"25","author":"Kono","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0105","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nri3901","article-title":"Regulation of innate immune cell function by mTOR","volume":"15","author":"Weichhart","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/nyas.12756","article-title":"mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging","volume":"1346","author":"Perl","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0115","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/08916934.2013.834495","article-title":"Metabolic control of the epigenome in systemic Lupus erythematosus","volume":"47","author":"Oaks","year":"2014","journal-title":"Autoimmunity"},{"key":"10.1016\/j.bbadis.2018.10.007_bb0120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaut.2016.03.001","article-title":"Increased 5-hydroxymethylcytosine in CD4(+) T cells in systemic lupus erythematosus","volume":"69","author":"Zhao","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0125","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1172\/JCI73411","article-title":"CaMK4-dependent activation of AKT\/mTOR and CREM-alpha underlies autoimmunity-associated Th17 imbalance","volume":"124","author":"Koga","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0130","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.4049\/jimmunol.1400044","article-title":"Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis","volume":"193","author":"Kshirsagar","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0135","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.4049\/jimmunol.1301005","article-title":"Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus","volume":"191","author":"Lai","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0140","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s11306-015-0772-0","article-title":"Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin","volume":"11","author":"Perl","year":"2015","journal-title":"Metabolomics"},{"key":"10.1016\/j.bbadis.2018.10.007_bb0145","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.immuni.2014.08.011","article-title":"The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatory responses and pathogenic antibody production","volume":"41","author":"Kobayashi","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2018.10.007_bb0150","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.18632\/aging.100925","article-title":"Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL\/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway","volume":"8","author":"Gu","year":"2016","journal-title":"Aging"},{"key":"10.1016\/j.bbadis.2018.10.007_bb0155","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/art.39791","article-title":"Mitochondrial dysfunction in the liver and antiphospholipid antibody production precede disease onset and respond to rapamycin in lupus-prone mice","volume":"68","author":"Oaks","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0160","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.4049\/jimmunol.1600813","article-title":"Cutting edge: direct sensing of TLR7 ligands and type I IFN by the common myeloid progenitor promotes mTOR\/PI3K-dependent emergency myelopoiesis","volume":"197","author":"Buechler","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0165","series-title":"Critical Roles of mTORC1 Signaling and Metabolic Reprogramming for M-CSF-mediated Myelopoiesis","first-page":"2629","volume":"vol. 214","author":"Karmaus","year":"2017"},{"key":"10.1016\/j.bbadis.2018.10.007_bb0170","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1158\/2159-8290.CD-15-1481","article-title":"Integrin-alpha10 dependency identifies RAC and RICTOR as therapeutic targets in high-grade myxofibrosarcoma","volume":"6","author":"Okada","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0175","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.4049\/jimmunol.180.7.5101","article-title":"A novel type I IFN-producing cell subset in murine lupus","volume":"180","author":"Lee","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0180","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1084\/jem.20080462","article-title":"TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus","volume":"205","author":"Lee","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0185","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1189\/jlb.3A0415-158R","article-title":"Immunosuppressive CD11b\u202f+\u202fLy6Chi monocytes in pristane-induced lupus mouse model","volume":"99","author":"Ma","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0190","article-title":"Assessing autophagy in mouse models and patients with systemic autoimmune diseases","volume":"6","author":"Wang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2018.10.007_bb0195","first-page":"271694","article-title":"Murine models of systemic lupus erythematosus","volume":"2011","author":"Perry","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.bbadis.2018.10.007_bb0200","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-1-4939-6780-3_21","article-title":"CD95 and the MRL-lpr mouse model","volume":"1557","author":"Flynn","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0205","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/icb.2014.99","article-title":"Double negative (DN) alphabeta T cells: misperception and overdue recognition","volume":"93","author":"Martina","year":"2015","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0210","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1084\/jem.178.6.2225","article-title":"Double-negative T cells from MRL-lpr\/lpr mice mediate cytolytic activity when triggered through adhesion molecules and constitutively express perforin gene","volume":"178","author":"Hammond","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0215","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.immuni.2013.02.007","article-title":"Tumor necrosis factor-alpha blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation","volume":"38","author":"Sade-Feldman","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2018.10.007_bb0220","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.immuni.2006.07.013","article-title":"Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus","volume":"25","author":"Christensen","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.bbadis.2018.10.007_bb0225","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4049\/jimmunol.1500071","article-title":"Type I IFN contributes to the phenotype of Unc93b1D34A\/D34A mice by regulating TLR7 expression in B cells and dendritic cells","volume":"196","author":"Fukui","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0230","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.4049\/jimmunol.174.7.4043","article-title":"Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN","volume":"174","author":"Bekeredjian-Ding","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0235","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.4049\/jimmunol.0803899","article-title":"Murine B cell response to TLR7 ligands depends on an IFN-beta feedback loop","volume":"183","author":"Green","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0240","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-med-052814-023338","article-title":"Importance of nucleic acid recognition in inflammation and autoimmunity","volume":"67","author":"Barrat","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0245","doi-asserted-by":"crossref","first-page":"73ra20","DOI":"10.1126\/scitranslmed.3001201","article-title":"Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus","volume":"3","author":"Garcia-Romo","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0250","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/art.21571","article-title":"The type I interferon system in systemic lupus erythematosus","volume":"54","author":"Ronnblom","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0255","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1084\/jem.20050914","article-title":"Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus","volume":"202","author":"Barrat","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0260","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI23025","article-title":"Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9","volume":"115","author":"Means","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0265","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-1-60761-720-4_10","article-title":"Analysis of renal mononuclear phagocytes in murine models of SLE","volume":"900","author":"Bethunaickan","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0270","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.4049\/jimmunol.180.3.1938","article-title":"Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis","volume":"180","author":"Schiffer","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0275","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/art.38410","article-title":"Structure and function of renal macrophages and dendritic cells from lupus-prone mice","volume":"66","author":"Sahu","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0280","series-title":"Myeloid-derived Suppressor Cells Coming of Age","first-page":"108","volume":"vol. 19","author":"Veglia","year":"2018"},{"key":"10.1016\/j.bbadis.2018.10.007_bb0285","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1158\/0008-5472.CAN-14-2331","article-title":"Host miR155 promotes tumor growth through a myeloid-derived suppressor cell-dependent mechanism","volume":"75","author":"Chen","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2018.10.007_bb0290","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/stem.2564","article-title":"Exosomal miR-146a contributes to the enhanced therapeutic efficacy of interleukin-1beta-primed mesenchymal stem cells against sepsis","volume":"35","author":"Song","year":"2017","journal-title":"Stem Cells"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918303843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443918303843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:42:25Z","timestamp":1760416945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443918303843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0925443918303843"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.10.007","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mTOR inhibitor INK128 attenuates systemic lupus erythematosus by regulating inflammation-induced CD11b+Gr1+ cells","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2018.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}